Modified virus takes on bile duct cancer in new trial
NCT ID NCT07522476
First seen Apr 14, 2026 · Last updated May 08, 2026 · Updated 5 times
Summary
This study tests a new treatment called VG2025 for people with advanced bile duct cancer that has spread. VG2025 is a modified virus designed to infect and kill cancer cells while boosting the immune system. The trial will enroll 30 adults to see if the treatment can shrink tumors and control the disease, building on earlier safety studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital，Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310003, China
Conditions
Explore the condition pages connected to this study.